Latest Stock Research & Market Analysis
Search All Research, Articles & Stock Profiles
ASX Stock Research
[BUY] Nick Scali (ASX: NCK): Margins, Growth and a Franked Yield
Institutional sell-side rates Nick Scali a Buy with a 12-month price target of around A$20. The stock closed at approximately A$14.47 on 9 May 2026, implying roughly 38 per cent upside before dividends. The thesis is built on three pillars: ANZ gross margins that sit...
[BUY] ResMed (ASX: RMD) – A New Product Cycle and a Cheap Multiple
ResMed reported its 3Q26 result this week. We are reiterating our Buy view on the stock with a price target of A$46.20, against a closing price of A$28.73 on 1 May 2026 and roughly 60.8 per cent upside to that target. The thesis is straightforward. Top-line growth...
[SELL] Macquarie Group (ASX: MQG) Why a 21% Rally Into Earnings Looks Stretched
Macquarie has rallied more than 21% in the past month, pushing the multiple to 24x forward earnings against a 10-year average of 16x. We walk through why the valuation looks stretched, the bull-case rebuttals (Aligned Data Centers, Qube), and why FY26 result on 8 May is the decision point.
[BUY] PWR Holdings (ASX: PWH) – De-risked and Returning to Growth
PWR Holdings (ASX PWH) - De-risked and Returning to Growth PWR Holdings (ASX: PWH) designs and manufactures advanced cooling solutions for the world's most demanding...
[BUY] BHP (ASX: BHP) Escondida Expansion Cements the Copper Growth Story
BHP has submitted a larger expansion proposal for the Escondida New Concentrator (ENC) project in Chile, upsizing the plant by roughly 20% and bringing forward an estimated...
Global Marco and Market Research
The Australian Consumer Was Already Last in the G10 on Spending. The RBA Hiked Anyway.
The G10 consumer dashboard puts Australian household spending growth dead last in the developed-market cohort. Tuesday’s RBA hike to 4.35 percent continues the squeeze. What that means for a domestic portfolio.
The Q1 CPI Was Mixed. The RBA Still Has to Hike on Tuesday.
The Reserve Bank Board meets on Monday and Tuesday next week with a rate decision at 2:30pm AEST on Tuesday. This is the most anticipated single-meeting call we have had in nine months. The case rests on a Q1 CPI print released on Wednesday that did two things at...
Why the Iran Oil Shock Points to More RBA Hikes, Not Fewer
The default narrative around the Iran conflict and the oil spike that has followed it is that it is bad news, full stop. Higher energy costs feed into inflation, dent consumer spending, and put pressure on central banks to either hold tight or cut rates to cushion the...
Global Stock Research
[BUY] Eli Lilly (LLY): Foundayo Reframes the Oral GLP-1 Story
LLY Buy with ~37% upside to ~US$1,283. 1Q26 EPS US$8.55 beat US$6.77, 2026 guide raised to US$82-85bn. Foundayo oral GLP-1 hits 8k prescribers in 3 weeks, 80% new incretin patients.
[HOLD] Tesla (NASDAQ: TSLA) A Strong Q1 But No Free Cash Flow Until 2028
Tesla (NASDAQ: TSLA) A Strong Q1 But No Free Cash Flow Until 2028 Tesla just delivered a first quarter result that was stronger than the market expected, with revenue beating the Street, automotive gross margins running well ahead of forecast, and energy storage...
[BUY] Corvus Pharmaceuticals (CRVS) – Novel and Differentiated Contender in Auto-Immune and Hematology
Corvus Pharmaceuticals has developed soquelitinib, a first-in-class oral ITK inhibitor targeting moderate-to-severe atopic dermatitis and relapsed/refractory peripheral T cell lymphoma. We initiate at Buy with a 12-month price target of $40.
[BUY] Broadcom (AVGO) – Three Hyperscaler Partnerships Lock In the Custom Silicon Growth Story
Broadcom has cemented its position as the dominant custom silicon and AI networking partner across the three largest US hyperscalers in the space of a single week. A long-term...
[BUY] Netflix (NFLX) – Platform Momentum and the Case for Re-Rating
Netflix (NFLX) - Platform Momentum and the Case for Re-Rating Netflix has pulled back 18% over the past six months while the broader S&P 500 has gained 2%, and we think that...
Region & Industry Outlook
Why China Is Pricing a Stability Premium
China has spent three years priced for an accident. In 2026 the macro picture has flipped, with growth holding above 4.5%, inflation reflating off the floor, USD/CNY rolling lower, and the equity wrappers leading the rerating off the 2024 lows.
Why Gold Miners Still Have Room to Run
Gold has had a turbulent few months. Spot gold ran from around US$3,400/toz at the end of 2025 to a peak above US$5,300/toz in early 2026 on a wave of speculative call-option demand and continued central bank diversification. The Iran shock in late March then...
Semis Are Still Riding the AI Capex Wave
The semiconductor cycle is in a constructive setup, with the AI capital expenditure build-out continuing to pull through capacity commitments, design wins, and sub-segment by sub-segment recoveries. March monthly shipment data from the Semiconductor Industry...
ASX Announcement
Fortescue (ASX: FMG) – Fortescue Receives Court Determination on Yindjibarndi Matter
Fortescue Ltd has been ordered by the Federal Court to pay compensation totalling approximately $150.1 million to the Yindjibarndi Ngurra Aboriginal Corporation in settlement of a Native Title Compensation Claim that commenced in 2022. The liability comprises economic...
Atlas Arteria (ASX: ALX) – Atlas Arteria Panel Receives Fourth Application
The Panel has received an application from Diamond Infraco 1 Pty Ltd, a subsidiary of IFM Global Infrastructure Fund, concerning governance arrangements related to Atlas Arteria's Chicago Skyway investment. The application arrives as IFM pursues an off-market takeover...
Dicker Data (ASX: DDR) – Dicker Data Declares Dividend Distribution
Dicker Data Limited has announced an ordinary dividend of AUD 0.115 per share, fully franked at the 30% corporate tax rate. The dividend represents a distribution for the quarter ending 31 March 2026 and will be paid on 2 June 2026 to shareholders on the register as...
Centuria Office REIT (ASX: COF) – Centuria Office Q3 FY26 Operating Update
Centuria Office REIT's Q3 FY26 update reveals a company making progress on leasing momentum while taking a measured approach to capital management in uncertain times. The REIT...
Centuria Industrial REIT (ASX: CIP) – Centuria Industrial Files Q3 FY26 Update
Centuria Industrial REIT (CIP) has demonstrated continued success in its asset recycling strategy, divesting $188 million worth of properties during the quarter at an average...
Top Stock Reports
5 Best Shares to Buy Right Now in Australia
Finding the best shares to buy on the ASX requires more than just scanning a screener or chasing whatever is up this week. We focus on companies with strong competitive positioning, visible earnings growth, and a catalyst to drive the share price higher over the next...
5 Best Dividend Stocks to Buy [ASX Blue Chip Stocks]
Dividend investing on the ASX remains one of the most reliable ways to build long-term wealth. Blue chip dividend stocks offer a combination of regular income and capital growth that is difficult to replicate through other strategies, particularly in an environment...
5 Best US Shares to Buy Right Now
US equities offer Australian investors access to some of the most innovative and fastest-growing companies in the world. The sheer depth of the American market means there are opportunities across sectors that simply do not exist on the ASX, from cutting-edge biotech...
Subscribe
Want more Free Research?
Subscribe today for free and get an alert when we have new research and webinars.
MF & Co. Asset Management
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Contact
Get In Touch
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000